Advanced Medical Solutions Group (AMS.L) Stock Analysis & Winston Score

Advanced Medical Solutions Group (AMS) makes products that help close and heal wounds. Its main products include surgical glues, sutures, staples, and wound dressings used in hospitals and clinics during and after surgery. The company sells to healthcare providers across Europe and beyond, and it also makes products that other medical companies sell under their own brand names. AMS earns money by selling its wound care and surgical products directly to hospitals and through distribution partners. It operates mainly in Europe, with a growing presence in the US and other international markets, and generates around £200–250 million in annual revenue. Its ability to manufacture products for other brands — known as private label or OEM supply — gives it a stable revenue base, but the company faces pressure from larger, better-resourced competitors like Johnson & Johnson and Smith & Nephew. The key growth driver is expanding its branded surgical products into the US market, where regulatory approvals and building a sales network remain the main hurdles.